ERBB2 and neoplasm: No significant differences were found in the correlation rates of EGFR or HER3 scores between different subgroups of clinicopathologic characteristics, or in the correlation rates of HER2 between different subgroups of gender, age, tumor type, primary tumor location, differentiation, T stage, and N stage.